Psoriasis drugs may weaken defenses against genital warts
NCT ID NCT07234838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines whether biologic treatments for moderate-to-severe psoriasis increase the chance of developing or having a return of genital warts. Researchers will review past medical records and follow 600 adults for two years to compare different treatments. They will also ask some participants about their willingness to get the HPV vaccine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOTHERAPIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Brugmann
RECRUITINGBrussels, Brussels Capital, 1020, Belgium
-
CHU Saint-Pierre
RECRUITINGBrussels, Brussels Capital, 1000, Belgium
-
Hôpital Erasme
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new gel calm psoriasis Flare-Ups?
- Can a Once-Daily cream tame psoriasis in toddlers?
- Can a switch to guselkumab clear stubborn psoriasis?
- Can a new biologic clear stubborn psoriasis?
- Diet and exercise may tame psoriasis in kids — a trial puts it to the test
- Ancient herbal mix put to the test against psoriasis